Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Barrett

Showing results (101-110 of 146) with videos related to

Pageof 15
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1974
The cardiovascular pharmacology of methyldopa using graphic segmental circulatory analysisM W Osborne, J J Wenger, R J Barrett, et al.
Life Sciences|April 13, 1987
Involvement of dopamine receptor subtypes in dopaminergic modulation of aldosterone secretion in ratsR J Barrett, K F Wright, D R Taylor, et al.
Gynecologic Oncology|February 1, 1994
Phase II trial of menogaril in patients with squamous carcinoma of the cervix: a Gynecologic Oncology Group studyG P Sutton, J A Blessing, R J Barrett, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1984
Effects of dopamine (DA) and SKF 82526, a selective DA1-receptor agonist, on vascular resistances in the canine forelimbG J Grega, R J Barrett, S W Adamski, et al.
Psychopharmacology|December 1, 1996
Rebound responding following a single dose of drug using an amphetamine-vehicle-haloperidol drug discriminationW F Caul, R J Barrett, E M Huffman, et al.
European Journal of Pharmacology|September 1, 1974
The influence of volume loading on the inotropic effect of Ro 7-2956M W Osborne, J J Wenger, M T Zanko, et al.
Behavioral Biology|July 1, 1974
Avoidance decrement as a function of training-test interval: single cycle or multiphasic?W F Caul, R J Barrett, G E Thune, et al.
Journal of Medicinal Chemistry|October 11, 1991
Synthesis, calcium-channel-blocking activity, and antihypertensive activity of 4-(diarylmethyl)-1-[3-(aryloxy)propyl]piperidines and structurally related compoundsJ R Shanklin, C P Johnson, A G Proakis, et al.
Journal of Cardiovascular Pharmacology|January 1, 1991
Cardiovascular and renal actions of AHR-16303B, an antagonist of 5-HT2 receptors and calcium channels, in hypertensive and normotensive ratsR J Barrett, K F Wright, A D Allen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1995
Effect of N-0861, a selective adenosine A1 receptor antagonist, on pharmacologic stress imaging with adenosineD K Glover, M Ruiz, V Sansoy, et al.
Pageof 15

Showing results (101-110 of 146) with videos related to

Sort By:
Pageof 15
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1974
The cardiovascular pharmacology of methyldopa using graphic segmental circulatory analysisM W Osborne, J J Wenger, R J Barrett, et al.
Life Sciences|April 13, 1987
Involvement of dopamine receptor subtypes in dopaminergic modulation of aldosterone secretion in ratsR J Barrett, K F Wright, D R Taylor, et al.
Gynecologic Oncology|February 1, 1994
Phase II trial of menogaril in patients with squamous carcinoma of the cervix: a Gynecologic Oncology Group studyG P Sutton, J A Blessing, R J Barrett, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1984
Effects of dopamine (DA) and SKF 82526, a selective DA1-receptor agonist, on vascular resistances in the canine forelimbG J Grega, R J Barrett, S W Adamski, et al.
Psychopharmacology|December 1, 1996
Rebound responding following a single dose of drug using an amphetamine-vehicle-haloperidol drug discriminationW F Caul, R J Barrett, E M Huffman, et al.
European Journal of Pharmacology|September 1, 1974
The influence of volume loading on the inotropic effect of Ro 7-2956M W Osborne, J J Wenger, M T Zanko, et al.
Behavioral Biology|July 1, 1974
Avoidance decrement as a function of training-test interval: single cycle or multiphasic?W F Caul, R J Barrett, G E Thune, et al.
Journal of Medicinal Chemistry|October 11, 1991
Synthesis, calcium-channel-blocking activity, and antihypertensive activity of 4-(diarylmethyl)-1-[3-(aryloxy)propyl]piperidines and structurally related compoundsJ R Shanklin, C P Johnson, A G Proakis, et al.
Journal of Cardiovascular Pharmacology|January 1, 1991
Cardiovascular and renal actions of AHR-16303B, an antagonist of 5-HT2 receptors and calcium channels, in hypertensive and normotensive ratsR J Barrett, K F Wright, A D Allen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1995
Effect of N-0861, a selective adenosine A1 receptor antagonist, on pharmacologic stress imaging with adenosineD K Glover, M Ruiz, V Sansoy, et al.
Pageof 15